Sertraline treatment influences [(18)F]FE-PE2I PET imaging for Parkinsonism

BACKGROUND: The dopamine transporter (DaT) PET ligand [(18)F]FE-PE2I is used to aid the diagnosis of Parkinson’s disease. After encountering four patients with a history of daily sertraline use, who all showed atypical findings on [(18)F]FE-PE2I PET, we suspected that the selective serotonin reuptak...

Descripción completa

Detalles Bibliográficos
Autores principales: Justesen, Thomas E. H., Borghammer, Per, Aanerud, Joel, Hovind, Peter, Marner, Lisbeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205964/
https://www.ncbi.nlm.nih.gov/pubmed/37221321
http://dx.doi.org/10.1186/s13550-023-01000-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205964/
https://www.ncbi.nlm.nih.gov/pubmed/37221321
http://dx.doi.org/10.1186/s13550-023-01000-6

Ejemplares similares